Insulin resistance can predict hypertension development, Wake Forest researchers report

November 15, 2000

How effectively the body uses the insulin it produces is directly related to risk of developing high blood pressure, reported researchers from Wake Forest University Baptist Medical Center today at the American Heart Association's annual conference.

"We found you can predict who's at higher risk for developing high blood pressure based on their insulin resistance," said David Goff Jr., Ph.D., M.D., the study's lead researcher. "This study increases our understanding of how hypertension develops and points out possible new treatment targets."

Goff and colleagues followed 809 middle-age adults who were enrolled in the Insulin Resistance Atherosclerosis Study (IRAS). When the study began, all of the participants had normal blood pressure and varying levels of resistance to insulin. Five years later, researchers found that participants who were most resistant to the effects of insulin had a higher incidence of high blood pressure.

"The one-third of participants with the highest levels of insulin resistance had rates of hypertension that were 35 percent higher than the one-third with the least resistance," said Goff, associate professor of public health sciences and internal medicine. "These findings point out that reducing the body's resistance to insulin may help prevent hypertension and cardiovascular disease."

Previously reported results from IRAS also pointed to insulin resistance as a possible new risk factor for cardiovascular disease. WFUBMC researchers showed that a high resistance to the effects of insulin is related to thickened blood vessel walls, an early sign of the hardening of the arteries that can cause heart attacks and strokes.

Insulin is produced by the pancreas to help the body use sugars, such as carbohydrates, as energy. By helping the body process these sugars, insulin prevents a buildup of sugar in the blood.

When the body's resistance to insulin is high, the pancreas may produce more insulin to process the sugar. Scientists suspect these higher levels of insulin may act directly on the artery wall to cause thickening, as well as to cause an increase in blood pressure and higher levels of fats circulating in the blood.

"A person with high insulin resistance may eventually develop diabetes, but the condition isn't the same thing as diabetes," said Goff. "With diabetes, the body doesn't produce enough insulin. With insulin resistance, higher-than-normal levels of insulin are often produced."

Goff said the test to measure insulin sensitivity is too complex to be used on a routine basis. It requires glucose and insulin to be injected intravenously and multiple blood samples taken over a three-hour period. However, he said most people can keep their levels of insulin resistance within normal ranges through exercise and maintaining a healthy weight.

"We've long known that exercise and weight control have multiple benefits," said Goff. "These results point out one more reason for their importance."
Media Contacts:
Karen Richardson, 336-716-4453,
Mark Wright, 336-716-3382,
or Jim Steele, 336-716-3487,

Wake Forest Baptist Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to